The initiative is calling for expressions of interest from Australian small and medium enterprises, including start-ups and research spin-offs, that are developing medical devices to prevent, diagnose, treat, or manage heart disease and complications linked to both type 1 and type 2 diabetes. …
MTPConnect launches new funding push to fast-track breakthroughs in heart disease and diabetes
February 23, 2026 Latest NewsAustralian Biotech
Latest Video
New Stories
-
Biogen ANZ certified a 'Great Place to Work' for a fifth time
October 16, 2026 - - Latest News -
Tavneos to be withdrawn from Australia as CSL pulls vasculitis treatment
October 16, 2026 - - Latest News -
AI in HTA - survey reveals optimism and concern over a potential missed opportunity
October 16, 2026 - - Latest News -
England's chief scientific officer on the opportunity for Australia to get it right on genomics
October 15, 2026 - - Latest News -
The medicines gap costing Australian children time they can't get back
October 15, 2026 - - Latest News -
Brain cancer advocates return to Canberra 'to keep that ambition alive'
October 15, 2026 - - Latest News -
The effort to change an institution from within, works best when exit is possible
October 15, 2026 - - Latest News